Skip to main navigation

Our Company
The Gift of Sight
Our Innovation
Investors + Media

Our Company
The Gift of Sight
- WHY SUPERIOR VISION
  OUTCOMES MATTER
Our Innovation
Investors & Media
NEWS
JOIN US
CONTACT US

LinkedIn
X

Search

Release Details

Overview
Stock Information
Press Releases
Events and Presentations
Filings
Corporate Governance
Investor Resources

Overview
Stock Information
Press Releases
Events and Presentations
Filings
Corporate Governance
Investor Resources

ASRS 2023 - PK and safety of sozinibercept (OPT-302)

August 1, 2023

efbf80bd-bdec-4e7e-a2ac-23c4c3cb0393.pdf 2 MB

Stay Informed

Contact Us Publications Investors + Media Request Investor Email Alerts

Locations

Opthea Limited

C/- Prime Company Compliance
Level 9, 505 little Collins Street,
Melbourne, Victoria 3000
Australia

Opthea US, Inc.

103 Carnegie Center Blvd
Suite 300
Princeton, New Jersey 08540
United States

Contact Us

LinkedIn
X

Our Company

About Us
Our Team
Our Culture

The Gift of Sight

Why Superior Vision
Outcomes Matter

Our Innovation

Pipeline
Science
Clinical Trials in Wet AMD
Clinical Trials in DME
Publications

Investors + Media

Overview
Stock Information
Press Releases
Presentations & Events
Filings
Corporate Governance
Investor Resources

© 2026 Opthea Limited. All rights reserved.

Privacy Policy
Terms of use
Disclaimer
Cookie Notice